Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells
Nobuharu Inaba1, Sho Ishizawa, Masaki Kimura
1Department of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, 1-5-30 Sibakoen, Minato-Ku, Tokyo 105-0011, Japan. n-inaba@jikei.ac.jp
Background:
Malignant glioma is one of the most intractable diseases in the human body. Rho-kinase (ROCK) is overexpressed and has been proposed as the main cause for the refractoriness of the disease. Since efficacious treatment is required, this study investigated the effect of inhibition of ROCK isoforms.
Materials And Methods:
The short hairpin RNA transcription vector was transfected into the RT2 rat glioma cell line and the characteristics of the cells were investigated. The effect of nimustine hydrochloride (ACNU) anti-neoplastic agent on cells was also measured.
Results:
Inhibition of ROCK isoforms did not alter cell growth. Cell cycle analysis revealed that ROCK1 down-regulation reduced the G(0) phase population and ROCK2 down-regulation reduced the G(2)/M phase population. When ROCK1-down-regulated cells were exposed to ACNU, they demonstrated susceptibility to the agent.
Conclusion:
The roles of ROCK1 and ROCK2 may be different in glioma cells. Furthermore, the combination of ROCK1 down-regulation and an anti-neoplastic agent may be useful for the therapy of malignant glioma.
Insights
Inhibiting Rho-kinase 1 (ROCK1) in glioma cells made them more sensitive to chemotherapy. This suggests combining ROCK1 inhibition with anti-cancer drugs could improve malignant glioma treatment.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Malignant glioma is a difficult-to-treat cancer.
- Rho-kinase (ROCK) is overexpressed in glioma, contributing to treatment resistance.
- Targeting ROCK isoforms is a potential therapeutic strategy.
Purpose of the Study:
- To investigate the effects of inhibiting Rho-kinase (ROCK) isoforms on glioma cells.
- To assess the impact of ROCK inhibition on cell cycle progression.
- To evaluate the combined effect of ROCK inhibition and nimustine hydrochloride (ACNU) on glioma cells.
Main Methods:
- Used short hairpin RNA (shRNA) to down-regulate ROCK1 and ROCK2 in RT2 rat glioma cells.
- Analyzed cell growth and cell cycle distribution.
- Assessed the sensitivity of ROCK-inhibited cells to nimustine hydrochloride (ACNU).
Main Results:
- ROCK isoform inhibition did not affect overall cell growth.
- ROCK1 down-regulation decreased the G(0) phase cell population.
- ROCK2 down-regulation decreased the G(2)/M phase cell population.
- ROCK1-down-regulated cells showed increased susceptibility to ACNU treatment.
Conclusions:
- ROCK1 and ROCK2 play distinct roles in glioma cell biology.
- Combining ROCK1 down-regulation with chemotherapy agents like ACNU may offer a new therapeutic approach for malignant glioma.
- Further research into ROCK isoform-specific targeting is warranted for glioma treatment.